North America dominates the Endotoxin Detection & Removal Kits market, accounting for 40% global share, driven by robust pharmaceutical R&D, stringent FDA regulations, and high adoption of advanced biotechnology. Regulatory priorities for sterility in injectables and growing biologics production further accelerate market growth. Europe follows with 25%, supported by EU Good Manufacturing Practices (GMP) and strong academic-industry collaborations, though slower growth is tempered by economic constraints. The Asia Pacific region, valued at 20%, is the fastest-growing, fueled by rapid industrialization, rising biotech investments in China and India, and expanding healthcare infrastructure in emerging economies.